HighTower Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.14M | Buy |
49,851
+37,892
| +317% | +$6.98M | 0.01% | 925 |
|
|
2025
Q4 | $2.1M | Buy |
11,959
+1,843
| +18% | +$301K | ﹤0.01% | 1638 |
|
|
2025
Q3 | $1.42M | Buy |
10,116
+1,245
| +14% | +$168K | ﹤0.01% | 1862 |
|
|
2025
Q2 | $1.11M | Sell |
8,871
-2,826
| -24% | -$352K | ﹤0.01% | 1945 |
|
|
2025
Q1 | $1.6M | Buy |
11,697
+3,312
| +39% | +$473K | ﹤0.01% | 1644 |
|
|
2024
Q4 | $1.28M | Sell |
8,385
-3,047
| -27% | -$514K | ﹤0.01% | 1797 |
|
|
2024
Q3 | $2.2M | Sell |
11,432
-2,335
| -17% | -$489K | ﹤0.01% | 1463 |
|
|
2024
Q2 | $3.16M | Sell |
13,767
-273
| -2% | -$59.3K | ﹤0.01% | 1208 |
|
|
2024
Q1 | $3.02M | Buy |
14,040
+309
| +2% | +$72.4K | ﹤0.01% | 1212 |
|
|
2023
Q4 | $3.57M | Buy |
13,731
+969
| +8% | +$238K | 0.01% | 1135 |
|
|
2023
Q3 | $3.3M | Sell |
12,762
-4,792
| -27% | -$1.28M | 0.01% | 1114 |
|
|
2023
Q2 | $4.98M | Sell |
17,554
-30
| -0.2% | -$8.93K | 0.01% | 905 |
|
|
2023
Q1 | $4.9M | Sell |
17,584
-8,323
| -32% | -$2.3M | 0.01% | 869 |
|
|
2022
Q4 | $7.17M | Buy |
25,907
+6,016
| +30% | +$1.7M | 0.02% | 707 |
|
|
2022
Q3 | $5.31M | Sell |
19,891
-11,597
| -37% | -$2.46M | 0.01% | 780 |
|
|
2022
Q2 | $6.42M | Buy |
31,488
+19,427
| +161% | +$3.97M | 0.02% | 712 |
|
|
2022
Q1 | $2.54M | Sell |
12,061
-2,013
| -14% | -$438K | 0.01% | 1234 |
|
|
2021
Q4 | $3.36M | Sell |
14,074
-5,271
| -27% | -$1.36M | 0.01% | 1096 |
|
|
2021
Q3 | $5.48M | Buy |
19,345
+385
| +2% | +$126K | 0.01% | 783 |
|
|
2021
Q2 | $6.57M | Sell |
18,960
-19,400
| -51% | -$5.88M | 0.02% | 695 |
|
|
2021
Q1 | $10.8M | Sell |
38,360
-124
| -0.3% | -$33.4K | 0.03% | 457 |
|
|
2020
Q4 | $9.37M | Buy |
38,484
+12,795
| +50% | +$3.3M | 0.04% | 388 |
|
|
2020
Q3 | $7.32M | Buy |
25,689
+6,023
| +31% | +$1.68M | 0.04% | 430 |
|
|
2020
Q2 | $5.27M | Sell |
19,666
-3,294
| -14% | -$990K | 0.03% | 498 |
|
|
2020
Q1 | $7.24M | Sell |
22,960
-1,894
| -8% | -$575K | 0.05% | 355 |
|
|
2019
Q4 | $7.39M | Buy |
24,854
+1,047
| +4% | +$291K | 0.04% | 420 |
|
|
2019
Q3 | $5.52M | Buy |
23,807
+5,915
| +33% | +$1.38M | 0.03% | 514 |
|
|
2019
Q2 | $4.19M | Sell |
17,892
-14,066
| -44% | -$3.25M | 0.02% | 622 |
|
|
2019
Q1 | $7.56M | Sell |
31,958
-4,673
| -13% | -$1.47M | 0.05% | 372 |
|
|
2018
Q4 | $11M | Buy |
36,631
+3,310
| +10% | +$1.06M | 0.08% | 244 |
|
|
2018
Q3 | $11.7M | Buy |
33,321
+863
| +3% | +$297K | 0.08% | 262 |
|
|
2018
Q2 | $9.42M | Buy |
32,458
+18,366
| +130% | +$5.16M | 0.07% | 286 |
|
|
2018
Q1 | $3.86M | Sell |
14,092
-8,937
| -39% | -$2.77M | 0.03% | 556 |
|
|
2017
Q4 | $7.33M | Sell |
23,029
-8,405
| -27% | -$2.7M | 0.06% | 353 |
|
|
2017
Q3 | $9.84M | Buy |
31,434
+2,238
| +8% | +$663K | 0.08% | 253 |
|
|
2017
Q2 | $7.92M | Sell |
29,196
-2,891
| -9% | -$764K | 0.07% | 309 |
|
|
2017
Q1 | $8.76M | Buy |
32,087
+6,535
| +26% | +$1.85M | 0.08% | 253 |
|
|
2016
Q4 | $7.26M | Buy |
25,552
+567
| +2% | +$168K | 0.08% | 267 |
|
|
2016
Q3 | $7.8M | Buy |
24,985
+8,604
| +53% | +$2.55M | 0.09% | 235 |
|
|
2016
Q2 | $3.95M | Sell |
16,381
-3,963
| -19% | -$1.04M | 0.05% | 402 |
|
|
2016
Q1 | $5.28M | Sell |
20,344
-633
| -3% | -$167K | 0.02% | 372 |
|
|
2015
Q4 | $6.42M | Buy |
20,977
+8,893
| +74% | +$2.56M | 0.08% | 276 |
|
|
2015
Q3 | $3.53M | Buy |
+12,084
| New | +$3.99M | 0.05% | 416 |
|
|
2015
Q2 | – | Sell |
-7,850
| Closed | -$3.31M | – | 1586 |
|
|
2015
Q1 | $3.31M | Buy |
7,850
+414
| +6% | +$163K | 0.05% | 426 |
|
|
2014
Q4 | $2.52M | Sell |
7,436
-19
| -0.3% | -$6.15K | 0.04% | 509 |
|
|
2014
Q3 | $2.47M | Sell |
7,455
-2,491
| -25% | -$821K | 0.04% | 472 |
|
|
2014
Q2 | $3.14M | Buy |
9,946
+187
| +2% | +$56.3K | 0.05% | 399 |
|
|
2014
Q1 | $2.98M | Sell |
9,759
-865
| -8% | -$275K | 0.06% | 383 |
|
|
2013
Q4 | $2.97M | Buy |
10,624
+4,928
| +87% | +$1.27M | 0.06% | 342 |
|
|
2013
Q3 | $1.37M | Sell |
5,696
-607
| -10% | -$136K | 0.03% | 527 |
|
|
2013
Q2 | $1.36M | Buy |
+6,303
| New | +$1.35M | 0.04% | 504 |
|
Other funds holding BIIB
VCM
VPM
HighTower Advisors's BIIB Position: Q1 2026 in Review
HighTower Advisors increased its Biogen (BIIB) stake by 317% in Q1 2026, buying an estimated $6.98M and bringing the position to 49,851 shares worth $9.14M. The position accounts for 0.01% of the portfolio, ranked #925.
HighTower Advisors first reported a position in BIIB in Q2 2013 and has held it in 51 quarters since. The position peaked at $11.7M in Q3 2018. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- HighTower Advisors held 49,851 shares of Biogen worth $9.14M as of Q1 2026.
- HighTower Advisors bought 37,892 Biogen shares in Q1 2026, an estimated $6.98M.
- Biogen made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #925 holding.
- HighTower Advisors first reported a position in Biogen in Q2 2013 and has held it in 51 quarters since.
- HighTower Advisors's Biogen position peaked at $11.7M in Q3 2018.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.